News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21247)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (1437)
Day
2 (21)
3 (134)
4 (182)
5 (180)
6 (174)
7 (76)
9 (47)
10 (146)
11 (152)
12 (93)
13 (140)
14 (92)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
9
10
11
12
13
14
Cardiovascular disease
Tenax shares nosedive as heart failure drug fails in Phase 3
Patients treated with Tenax Therapeutics’ heart failure drug TNX-103 did not show significantly better functional performance—though Leerink analysts found biomarker improvements and subgroup analyses in elderly and more severe patients “very encouraging.”
August 10, 2026
·
2 min read
·
Tristan Manalac
Press Releases
NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
August 10, 2026
·
19 min read
Press Releases
Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx’s DNA Polymerase IIIC Inhibitor Antibiotics
August 10, 2026
·
10 min read
Press Releases
Fasenra® (benralizumab) now approved in Canada for hypereosinophilic syndrome
August 10, 2026
·
4 min read
Press Releases
Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results
August 10, 2026
·
1 min read
Press Releases
Acarix Receives Regulatory Approval for the CADScor® System in the UAE (United Arab Emirates)
August 10, 2026
·
3 min read
Press Releases
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
August 10, 2026
·
2 min read
Press Releases
Quanterix Names Jim Gute Chief Commercial Officer
August 10, 2026
·
6 min read
Press Releases
Quanterix Releases Financial Results for the Second Quarter of 2026
August 10, 2026
·
19 min read
Manufacturing
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade.
August 10, 2026
·
2 min read
·
Nick Paul Taylor
Previous
4 of 15
Next
